How long can a person with moderate thalassemia live?

Jun 01, 2022 Source: Cainiu Health
Dr. Pan Yongyuan
Introduction
The life expectancy of individuals with moderate thalassemia depends on the treatment stage and specific therapeutic approach; therefore, no definitive survival duration can be specified. If a patient with moderate thalassemia undergoes allogeneic hematopoietic stem cell transplantation promptly after diagnosis, they may achieve a normal life expectancy.

Some patients with intermediate thalassemia worry about having a shortened lifespan and fear sudden death, causing significant psychological distress. So, how long can individuals with intermediate thalassemia live?

How long can individuals with intermediate thalassemia live?

The life expectancy of individuals with intermediate thalassemia varies depending on the stage of treatment and the specific therapeutic approach employed; therefore, no definitive life expectancy can be stated. If hematopoietic stem cell transplantation is performed promptly and actively following diagnosis of intermediate thalassemia, patients may achieve a normal life expectancy.

However, if patients do not receive effective iron-chelation therapy or regular blood transfusions after diagnosis, their life expectancy is significantly reduced—typically not exceeding 20 years. With timely and appropriate treatment, however, survival can be substantially extended, often to approximately 35–36 years. Moreover, patients without severe complications who receive intermittent red blood cell transfusion support may still attain a normal life expectancy.

Additionally, individuals diagnosed with intermediate thalassemia are advised to maintain a positive mental outlook. Engaging in moderate physical exercise regularly can help improve overall physical fitness and enhance immune function, thereby optimizing treatment outcomes. We hope this information is helpful to you!